LEVERKUSEN, GERMANY – Bayer confirms advanced negotiations with Monsanto concerning a proposed transaction. While key terms and conditions have not yet been agreed, Bayer would be prepared to provide a transaction consideration of $127.50 per Monsanto share only in connection with a negotiated transaction. There can be no assurance that the parties will enter into an agreement.
The proposed transaction would be subject to regulatory approval and other customary closing conditions. The key conditions of a definitive transaction agreement must be approved by the Supervisory Board of Bayer AG.
For more information, visit www.advancingtogether.com.
The proposed transaction would be subject to regulatory approval and other customary closing conditions. The key conditions of a definitive transaction agreement must be approved by the Supervisory Board of Bayer AG.
For more information, visit www.advancingtogether.com.
Latest from Garden Center
- Weekend Reading 9/27/24
- Bushel and Berry expands collection with two non-berry plant introductions
- Space jam
- OMRI products added to CABI BioProtection portal
- Dümmen Orange North America hires two horticulturists
- Espoma Organic releasing Greenrock mineral supplement in spring 2025
- American Horticultural Society receives three awards at GardenComm annual conference
- Fertile Ground Webinar Series replay: Email, SMS and Loyalty Programs
